AU2001267687A1 - Ruthenium (ii) compounds for use in the therapy of cancer - Google Patents

Ruthenium (ii) compounds for use in the therapy of cancer

Info

Publication number
AU2001267687A1
AU2001267687A1 AU2001267687A AU6768701A AU2001267687A1 AU 2001267687 A1 AU2001267687 A1 AU 2001267687A1 AU 2001267687 A AU2001267687 A AU 2001267687A AU 6768701 A AU6768701 A AU 6768701A AU 2001267687 A1 AU2001267687 A1 AU 2001267687A1
Authority
AU
Australia
Prior art keywords
cancer
compounds
ruthenium
therapy
sup
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267687A
Other languages
English (en)
Inventor
Haimei Chen
Duncan Jodrell
Robert Edward Morris Jr.
Peter John Sadler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Edinburgh
Original Assignee
University of Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Edinburgh filed Critical University of Edinburgh
Publication of AU2001267687A1 publication Critical patent/AU2001267687A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00—Metallocenes
    • C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046—Ruthenium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001267687A 2000-06-30 2001-06-26 Ruthenium (ii) compounds for use in the therapy of cancer Abandoned AU2001267687A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0016052 2000-06-30
GBGB0016052.3A GB0016052D0 (en) 2000-06-30 2000-06-30 Ruthenium (II) compounds
PCT/GB2001/002824 WO2002002572A1 (en) 2000-06-30 2001-06-26 Ruthenium (ii) compounds for use in the therapy of cancer

Publications (1)

Publication Number Publication Date
AU2001267687A1 true AU2001267687A1 (en) 2002-01-14

Family

ID=9894730

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267687A Abandoned AU2001267687A1 (en) 2000-06-30 2001-06-26 Ruthenium (ii) compounds for use in the therapy of cancer

Country Status (14)

Country Link
US (1) US6936634B2 (enExample)
EP (1) EP1294732B1 (enExample)
JP (1) JP2004502696A (enExample)
AT (1) ATE273985T1 (enExample)
AU (1) AU2001267687A1 (enExample)
BR (1) BR0112122A (enExample)
CA (1) CA2414446A1 (enExample)
DE (1) DE60105028T2 (enExample)
DK (1) DK1294732T3 (enExample)
ES (1) ES2227225T3 (enExample)
GB (1) GB0016052D0 (enExample)
MX (1) MXPA02012911A (enExample)
PT (1) PT1294732E (enExample)
WO (1) WO2002002572A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1224192B1 (en) * 1999-10-27 2005-08-31 The University Court, The University Of Edinburgh Half-sandwich ruthenium (ii) compounds comprising nitrogen containing ligands for treatment of cancer
AU2002346686A1 (en) * 2001-12-07 2003-06-23 Intermune, Inc. Compositions and method for treating hepatitis virus infection
GB0215526D0 (en) * 2002-07-05 2002-08-14 Univ Edinburgh Anticancer compounds
AU2004234127A1 (en) 2003-04-30 2004-11-11 The University Court Of The University Of Edinburgh Ruthenium (II) complexes for the treatment of tumors
GB0418643D0 (en) * 2004-08-20 2004-09-22 Univ Edinburgh Ruthenium (II) compounds
GB0604602D0 (en) * 2006-03-07 2006-04-19 Univ Edinburgh Ruthenium (II) compounds
GB0610062D0 (en) * 2006-05-19 2006-06-28 Univ Edinburgh Ruthenium (ll) compounds
CN101851256B (zh) * 2010-04-30 2013-01-09 广东药学院 一种以柔性碳链联接的钌(ⅱ)卟啉配合物及其制备方法和应用
CN101863925B (zh) * 2010-05-21 2012-08-29 广东药学院 一种芳基钌(ⅱ)配合物及其制备方法和应用
US9751081B2 (en) 2014-12-01 2017-09-05 Clemson University Self-regenerating antioxidant catalysts and methods of using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980472A (en) 1983-06-23 1990-12-25 American Cyanamid Company Method of making (3-amino-1H-pyrazol-4-yl) (aryl)methanones
AU570826B2 (en) 1984-07-24 1988-03-24 Asta-Pharma Aktiengesellschaft Ruthenium compounds having a tumor inhibiting activity
WO1986000804A1 (fr) 1984-07-24 1986-02-13 Byk Gulden Lomberg Chemische Fabrik Gesellschaft M Compositions de ruthenium a effet inhibiteur de tumeurs
US4980473A (en) * 1985-01-18 1990-12-25 The Trustees Of Columbia University In The City Of New York Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents
US5225556A (en) 1985-01-18 1993-07-06 The Trustees Of Columbia University In The City Of New York Chemical probes for left-handed DNA and for A-DNA; chiral metal complexes as Z-specific antitumor agents and as double strand cleavers
US4699978A (en) 1985-01-18 1987-10-13 The Trustees Of Columbia University In The City Of New York Site-specific chiral ruthenium (II) and cobalt (III) antitumor agents
AU4017695A (en) 1994-10-28 1996-05-23 Procept, Inc. Ruthenium complexes and their use as immunosuppressive agents
JPH11209314A (ja) 1997-09-30 1999-08-03 Takasago Internatl Corp シクロオクタジエン類の製造方法
JP3488103B2 (ja) * 1998-11-12 2004-01-19 高砂香料工業株式会社 ４−メチル−５−ヘキセン−１−アールを含有する香料組成物
GB0028025D0 (en) 2000-11-17 2001-01-03 Univ York Compounds

Also Published As

Publication number Publication date
DK1294732T3 (da) 2004-12-06
MXPA02012911A (es) 2004-07-30
US20040029852A1 (en) 2004-02-12
PT1294732E (pt) 2004-12-31
ES2227225T3 (es) 2005-04-01
BR0112122A (pt) 2003-05-13
US6936634B2 (en) 2005-08-30
JP2004502696A (ja) 2004-01-29
DE60105028D1 (de) 2004-09-23
WO2002002572A1 (en) 2002-01-10
ATE273985T1 (de) 2004-09-15
EP1294732A1 (en) 2003-03-26
DE60105028T2 (de) 2005-08-18
EP1294732B1 (en) 2004-08-18
CA2414446A1 (en) 2002-01-10
GB0016052D0 (en) 2000-08-23

Similar Documents

Publication Publication Date Title
ES2133807T3 (es) Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas.
PL358281A1 (en) Novel compounds
MY119403A (en) Novel compounds with analgesic effect.
MY132705A (en) Novel compounds with analgesic effect
GEP20053688B (en) Substituted-Triazolopyrimidines as Anticancer Agents
GEP20032922B (en) Benzoheterocycles and Their Use as MEK Inhibitors
BG106586A (en) Pyrazolopyramidines as therapeutic agents
GEP20063799B (en) Tropane derivatives useful in therapy
AU7278500A (en) Fungicides
AU3850600A (en) Dalda analogs and their use
IT1285770B1 (it) Composti corticoidei
NZ513096A (en) Compositions for treating inflammatory response
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
IL150125A0 (en) Novel compounds
GB0016052D0 (en) Ruthenium (II) compounds
AU2001291725A1 (en) Heterocyclic mutilin esters and their use as antibacterials
HUT73529A (en) New bis-naphthalimides for the treatment of cancer
GB0215526D0 (en) Anticancer compounds
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
GB0027705D0 (en) Novel compounds
AUPQ866500A0 (en) Therapeutic compounds and methods
YU46302A (sh) Supstituisani piroli
SE0004827D0 (sv) Therapeutic compounds
ZA200209835B (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or anti-metabolites.